Phio Pharmaceuticals Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 08/14/2026 | 117.76 K | $120.70 K | -1.20% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 114.57 K | $117.44 K | -22.19% | 0.99% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 94.26 K | $96.62 K | 18.04% | 0.81% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 50.00 K | $51.00 K | 100.00% | 0.43% |
| CETERA INVESTMENT ADVISERS | 08/12/2026 | 47.50 K | $48.69 K | 5.56% | 0.41% |
| CITADEL ADVISORS LLC | 09/02/2026 | 47.15 K | $48.33 K | 100.00% | 0.41% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 38.17 K | $39.12 K | 0.00% | 0.33% |
| NORTHERN TRUST CORP | 08/13/2026 | 27.77 K | $28.46 K | 16.88% | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 21.50 K | $22.04 K | -33.83% | 0.19% |
| XTX TOPCO LTD | 08/14/2026 | 18.48 K | $18.94 K | -25.71% | 0.16% |
| HRT FINANCIAL LP | 08/14/2026 | 13.18 K | $13.00 K | -62.05% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 12.00 K | $12.30 K | 100.00% | 0.10% |
| CITIGROUP INC | 08/03/2026 | 11.61 K | $11.90 K | 1,032.20% | 0.10% |
| CAPTRUST FINANCIAL ADVISORS | 08/13/2026 | 10.00 K | $10.25 K | 0.00% | 0.09% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 6.21 K | $6.36 K | -18.56% | 0.05% |
| MORGAN STANLEY | 08/13/2026 | 6.00 K | $6.15 K | 0.00% | 0.05% |
| UBS GROUP AG | 08/13/2026 | 5.39 K | $5.52 K | -80.04% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 2.00 K | $2.06 K | 0.00% | 0.02% |
| SPIRE WEALTH MANAGEMENT | 07/15/2026 | 1.99 K | $2.05 K | -0.50% | 0.02% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 1.25 K | $1.28 K | 1.88% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 231 | $237 | 100.00% | 0.00% |
| ASSETMARK, INC | 07/30/2026 | 110 | $113 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 07/16/2026 | 9 | $9 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 6 | $6 | 100.00% | 0.00% |
| NBC SECURITIES, INC. | 07/21/2026 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phio Pharmaceuticals Corp institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Phio Pharmaceuticals Corp. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 117,755
GEODE CAPITAL MANAGEMENT, LLC: 114,574
VANGUARD CAPITAL MANAGEMENT LLC: 94,262
MACQUARIE MANAGEMENT HOLDINGS, INC.: 50,000
Cetera Investment Advisers: 47,500
CITADEL ADVISORS LLC: 47,150
5.57% of Phio Pharmaceuticals Corp stock is owned by institutional investors.
Institutional investors have bought a total of 734.76 K shares in the last 24 months. This purchase volume represents approximately $889.05 K in transactions.